Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity.
about
Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDSCDCP1 identifies a CD146 negative subset of marrow fibroblasts involved with cytokine production.The role of the marrow microenvironment in hematopoietic stem cell transplantation.Phosphorylation of FOXP3 by LCK downregulates MMP9 expression and represses cell invasion.Myelodysplasia is in the niche: novel concepts and emerging therapies.Biology of BM failure syndromes: role of microenvironment and niches.Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome.The Systemic Profile of Soluble Immune Mediators in Patients with Myelodysplastic Syndromes.Intracellular regulation of matrix metalloproteinase-2 activity: new strategies in treatment and protection of heart subjected to oxidative stressFunctionally and phenotypically distinct subpopulations of marrow stromal cells are fibroblast in origin and induce different fates in peripheral blood monocytes.The mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine.Involvement of SDF-1 and monocyte chemoattractant protein-1 in hydrogen peroxide-induced extracellular matrix degradation in human dental pulp cells.Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.
P2860
Q33733541-B93B799F-2954-4B0A-956F-0732DF6E1367Q34282531-462A7ECB-3D35-4CC3-8A06-3F1F2ACA4C0AQ34485594-3BD4B7A6-F5A2-431E-BA64-CD92859D57CEQ35025355-20664BDE-B6A2-4094-9C5D-E4B66EC9F7C7Q35059425-30CAF4EF-8CD5-40ED-8FB7-991A12FA310EQ35568527-74573A6E-4C71-4221-931A-73D5726FEAEAQ36547805-291B71E7-5509-4ADE-BE13-980679B2EBC6Q36988558-5E01BA21-C62E-4941-9D42-4F39C332A335Q37134517-F037411C-0B18-4C3A-89B0-3B709F15312FQ37456901-073B46A8-2922-4FC1-81EF-0B46C218F39FQ37667542-6EEF0E0A-D912-45D8-8009-70E4645FDBCCQ37910044-94E3C8BF-10E3-469A-80D3-D9F4438ADF5CQ43788189-5C11D40D-B234-4AE1-8B66-8393BD861335Q46849209-4DE105EB-9B85-423B-9DEB-EF31D3BA505BQ47610191-56A20FA5-3F45-4616-8B43-57E499EE01D7
P2860
Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Reduced expression of inducibl ...... s and with marrow cellularity.
@ast
Reduced expression of inducibl ...... s and with marrow cellularity.
@en
type
label
Reduced expression of inducibl ...... s and with marrow cellularity.
@ast
Reduced expression of inducibl ...... s and with marrow cellularity.
@en
prefLabel
Reduced expression of inducibl ...... s and with marrow cellularity.
@ast
Reduced expression of inducibl ...... s and with marrow cellularity.
@en
P2093
P2860
P1433
P1476
Reduced expression of inducibl ...... s and with marrow cellularity.
@en
P2093
Aravind Ramakrishnan
Beverly Torok-Storb
Manoj Pillai
Mineo Iwata
Robert C Hackman
P2860
P356
10.1182/BLOOD-2006-05-020289
P407
P577
2007-01-01T00:00:00Z